Abbott Laboratories (ABT)

Check out top investors' recommendation for ABT
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
78.00
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
100%/0%
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Glenn Novarro RBC Capital Markets Buy   Oct 10, '18     77.00  Oct 10, '19  N/A 
Josh Jennings Cowen And Company Buy   Oct 05, '18     86.00  Oct 05, '19  N/A 
John Ransom Raymond James Buy   Sep 24, '18     77.00  Sep 24, '19  N/A 
David Lewis Morgan Stanley Buy   Sep 24, '18     70.00  Sep 24, '19  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Sep 24, '18     80.00  Sep 24, '19  N/A 
David Toung Argus Research Company Buy   Jan 30, '18     80.00  Jan 30, '19  N/A 
Matthew Taylor National Bank Financial Buy   Jan 25, '18     70.00  Jan 25, '19  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Jan 25, '18     70.00  Jan 25, '19  N/A 
Brian Weinstein William Blair & Company, L.L.C. Buy   Jan 25, '18       Jan 25, '19  N/A 
Glenn Novarro RBC Capital Markets Buy   Jan 24, '18     67.00  Jan 24, '19  N/A 
Joanne Wuensch BMO Capital Markets Buy   Jan 24, '18     70.00  Jan 24, '19  N/A 
David Lewis Morgan Stanley Buy   Jan 02, '18     67.00  Jan 02, '19  N/A 
Joanne Wuensch BMO Capital Markets Buy   Dec 12, '17     65.00  Dec 12, '18  N/A 
Raj Denhoy Jefferies & Co. Buy   Oct 10, '17     58.00  Oct 10, '18  N/A 
Glenn Novarro RBC Capital Markets Buy   Oct 09, '17       Oct 09, '18  N/A 
Matthew Taylor National Bank Financial Buy   Sep 28, '17     60.00  Sep 28, '18  N/A 
Larry Biegelsen Wells Fargo Securities, Llc Buy   Sep 28, '17     64.00  Sep 28, '18  N/A 
Rick Wise Stifel Nicolaus & Company, Inc. Buy   Sep 22, '17     58.00  Sep 22, '18  N/A 
Josh Jennings Cowen And Company Buy   Sep 22, '17     55.00  Sep 22, '18  N/A 
Raj Denhoy Jefferies & Co. Buy   Sep 05, '17     58.00  Sep 05, '18  N/A 
< previous1234